Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892.
N Engl J Med. 2020.
PMID: 31914241
Clinical Trial.